Multifaceted effects of antimetabolite and anticancer drug, 2‐deoxyglucose on eukaryotic cancer models budding and fission yeast
Multifaceted effects of antimetabolite and anticancer drug, 2‐deoxyglucose on eukaryotic cancer models budding and fission yeast
复制标题
抗代谢物和抗癌药物 2-脱氧葡萄糖对真核癌症模型芽殖和裂殖酵母的多方面影响
DOI:
--
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
C. J. D'Souza
中科院分区:
文献类型:
--
作者:
A. Vishwanatha;C. J. D'Souza
Glycolytic inhibitors are of interest therapeutically as they are effective against cancers that display increased glycolytic rate and mitochondrial defects. 2‐Deoxyglucose (2‐DG) is one such glycolytic inhibitor and was identified to be a competitive inhibitor of glucose. Studies from past few decades have shown that the mechanism of action of 2‐DG is complex involving several metabolic and signaling pathways. Budding yeast Saccharomyces cerevisiae and fission yeast Schizosaccharomyces pombe are two important models for studying metabolism, cell cycle and cell signaling. These two unicellular eukaryotes are Crabtree positive yeasts exhibiting a metabolism similar to that of cancer cells. Effects of 2‐DG in yeast is of interest owing to these similarities and hence yeasts have emerged as ideal model organisms to study the mode of action and resistance to 2‐DG. In this review, we summarize the studies on biological effect and resistance to 2‐DG in budding and fission yeasts and give an insight into its possible mechanism of action as models for understanding cancer metabolism and drugs affecting cancer progression. © 2017 IUBMB Life, 69(3):137–147, 2017
登录
查看更多内容
影响因子:
11.2
作者:
Pelicano H;Lu W;Zhou Y;Zhang W;Chen Z;Hu Y;Huang P
通讯作者:
Huang P
影响因子:
3.3
作者:
L. Neigeborn;M. Carlson
通讯作者:
L. Neigeborn;M. Carlson
影响因子:
50.3
作者:
Ward PS;Thompson CB
通讯作者:
Thompson CB
影响因子:
3.9
作者:
Hoffman, CS
通讯作者:
Hoffman, CS